Literature DB >> 15001689

Dynamic imaging of striatal D2 receptors in mice using quad-HIDAC PET.

Michael Honer1, Matthias Brühlmeier, John Missimer, August P Schubiger, Simon M Ametamey.   

Abstract

UNLABELLED: The novel, dedicated small animal PET tomograph, quad-HIDAC, offers submillimeter resolution in instrumental characterization experiments. The aim of this study was to establish the tomograph's utility in a biologic application and to demonstrate the feasibility of rapid dynamic neuroreceptor imaging in mice.
METHODS: We used the well-established, high-affinity dopamine D(2) receptor PET ligand (18)F-fallypride for imaging striatal D(2) receptors in NMRI mice. Dynamic PET data were acquired using the quad-HIDAC tomograph and subject to 2 different kinetic modeling approaches. The cerebellum, a brain region devoid of D(2) receptors, was chosen as a reference region for kinetic modeling.
RESULTS: The resolution of the quad-HIDAC camera allowed clear visualization of the left and right mouse striatum with high target-to-nontarget signal ratios. The sensitivity of the tomograph permitted the generation of time-activity curves with initial time frames of 120 s. PET experiments acquiring data for 150 min demonstrated that the binding potential of (18)F-fallypride could be fitted robustly with both reference tissue models for scan durations of >or=40 min. Voxel-wise modeling resulted in parametric maps of high quality. The values for the binding potential in the striatum reached approximately 14, consistent with striatum-to-cerebellum ratios extracted from regional time-activity curves. Comparison of in vivo PET imaging results with ex vivo postmortem tissue sampling analyses indicated discrepancies in signal intensity, possibly resulting from scatter and random background in the cerebellum region of interest and leading to an overestimation of cerebellar activity concentrations and degradation of striatum-to-cerebellum ratios in PET experiments. Intraperitoneal injection of the unlabeled D(2) receptor antagonist haloperidol 30 min before intravenous injection of (18)F-fallypride blocked tracer accumulation in the striatum by >95%.
CONCLUSION: The quad-HIDAC camera represents a powerful tool for future dynamic neuroreceptor PET studies in mice and rats under numerous pharmacologic or pathophysiologic conditions.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15001689

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  16 in total

1.  In vivo imaging of inflammation- and tumor-induced lymph node lymphangiogenesis by immuno-positron emission tomography.

Authors:  Viviane Mumprecht; Michael Honer; Benjamin Vigl; Steven T Proulx; Eveline Trachsel; Manuela Kaspar; Nadja E Banziger-Tobler; Roger Schibli; Dario Neri; Michael Detmar
Journal:  Cancer Res       Date:  2010-10-26       Impact factor: 12.701

Review 2.  Novel detector technology for clinical PET.

Authors:  Roger Lecomte
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-03       Impact factor: 9.236

3.  Performing radiosynthesis in microvolumes to maximize molar activity of tracers for positron emission tomography.

Authors:  Maxim E Sergeev; Mark Lazari; Federica Morgia; Jeffrey Collins; Muhammad Rashed Javed; Olga Sergeeva; Jason Jones; Michael E Phelps; Jason T Lee; Pei Yuin Keng; R Michael van Dam
Journal:  Commun Chem       Date:  2018-03-22

4.  Inflammation-induced lymph node lymphangiogenesis is reversible.

Authors:  Viviane Mumprecht; Filip Roudnicky; Michael Detmar
Journal:  Am J Pathol       Date:  2011-12-23       Impact factor: 4.307

5.  Longitudinal and multimodal in vivo imaging of tumor hypoxia and its downstream molecular events.

Authors:  Steffi Lehmann; Daniel P Stiehl; Michael Honer; Marco Dominietto; Ruth Keist; Ivana Kotevic; Kristin Wollenick; Simon Ametamey; Roland H Wenger; Markus Rudin
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-31       Impact factor: 11.205

6.  Titania-catalyzed radiofluorination of tosylated precursors in highly aqueous medium.

Authors:  Maxim E Sergeev; Federica Morgia; Mark Lazari; Christopher Wang; R Michael van Dam
Journal:  J Am Chem Soc       Date:  2015-04-22       Impact factor: 15.419

7.  Exercise elevates dopamine D2 receptor in a mouse model of Parkinson's disease: in vivo imaging with [¹⁸F]fallypride.

Authors:  Marta G Vučković; Quanzheng Li; Beth Fisher; Angelo Nacca; Richard M Leahy; John P Walsh; Jogesh Mukherjee; Celia Williams; Michael W Jakowec; Giselle M Petzinger
Journal:  Mov Disord       Date:  2010-12-15       Impact factor: 10.338

8.  Synthesis and preclinical evaluation of a new C-6 alkylated pyrimidine derivative as a PET imaging agent for HSV1-tk gene expression.

Authors:  Ursina Müller; Tobias L Ross; Charlene Ranadheera; Roger Slavik; Adrienne Müller; Mariana Born; Evelyn Trauffer; Selena Milicevic Sephton; Leonardo Scapozza; Stefanie D Krämer; Simon M Ametamey
Journal:  Am J Nucl Med Mol Imaging       Date:  2013-01-05

9.  Imaging dopaminergic dysfunction as a surrogate marker of neuropathology in a small-animal model of HIV.

Authors:  Dianne E Lee; William C Reid; Wael G Ibrahim; Kristin L Peterson; Margaret R Lentz; Dragan Maric; Peter L Choyke; Elaine M Jagoda; Dima A Hammoud
Journal:  Mol Imaging       Date:  2014       Impact factor: 4.488

10.  Synthesis of [F]fallypride in a micro-reactor: rapid optimization and multiple-production in small doses for micro-PET studies.

Authors:  Shuiyu Lu; Anthony M Giamis; Victor W Pike
Journal:  Curr Radiopharm       Date:  2009
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.